Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
β Scribed by M. Masetti; R. Montalti; G. Rompianesi; M. Codeluppi; R. Gerring; A. Romano; B. Begliomini; F. Di Benedetto; G. E. Gerunda
- Book ID
- 114805596
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 358 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Early renal dysfunction following liver transplantation is associated with increased morbidity and mortality. To evaluate the impact of delayed initiation of calcineurin inhibitor on renal function, we conducted a retrospective study comparing 118 liver transplant recipients who received rabbit anti
Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro